US Stock MarketDetailed Quotes

LEGN Legend Biotech

Watchlist
  • 54.370
  • +5.870+12.10%
Close Jul 12 16:00 ET
  • 53.990
  • -0.380-0.70%
Post 19:59 ET
9.91BMarket Cap-21073P/E (TTM)

Legend Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Legend Biotech Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 13, 2024

Revenue(YoY)

93.99M

+158.67%
EPS(YoY)

-0.32

+52.94%
Analyst Rating

Strong Buy

Jul 3, 2024

Legend Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 142.347M--
Aug 9, 20242024/Q2-- / 123.361M--
May 13, 20242024/Q193.991M / 141.359M--
Mar 11, 20242023/Q479.464M / 95.662M--
Nov 20, 20232023/Q396.013M / 99.511M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 142.347M--
Aug 9, 20242024/Q2-- / 123.361M--
May 13, 20242024/Q193.991M / 141.359M--
Mar 11, 20242023/Q479.464M / 95.662M--
Nov 20, 20232023/Q396.013M / 99.511M--

Unlock Free Earnings Estimates

Legend Biotech Earnings Reports

  • Legend Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

    May 13 07:04 ET

  • Legend Biotech | 20-F: Registration statement / Annual report / Transition report

    Mar 19 07:06 ET

  • Legend Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 11 07:56 ET

  • Legend Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 20, 2023 06:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 3, 2024

    Strong Buy

    • Buy

      93.33%

    • Hold

      6.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept China Concept Stocks
    China Concept Stocks
    Intraday+1.31%
    Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+0.91%